difference between glp 1 and sglt2 vs GLP-1 for CKD: Which Is Better? Journal of Lancaster General Health

The semaglutide segment dominates the market with a share of 71% due to its proven efficacy in controlling blood glucose and promoting weight loss

GLP1R agonists such as liraglutide and semaglutide are widely used to restore normal blood glucose levels in patients with type 2 diabetes (T2D) and to manage body weight in individuals with obesity

Aside from facilitating access, many drugmakers want a piece of the pie, as the global obesity therapies market is expected to hit $150 billion in sales over the next decade

This is probably due to the effectiveness of GLP1-RAs in reducing glucose

Its vision also includes environmental responsibility